Jean-Charles Soria to Receptor, Fibroblast Growth Factor, Type 1
This is a "connection" page, showing publications Jean-Charles Soria has written about Receptor, Fibroblast Growth Factor, Type 1.
Connection Strength
0.221
-
First-in-human phase I study of oral S49076, a unique MET/AXL/FGFR inhibitor, in advanced solid tumours. Eur J Cancer. 2017 08; 81:142-150.
Score: 0.177
-
A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers. Clin Cancer Res. 2017 Sep 15; 23(18):5366-5373.
Score: 0.044